E. S. Henderson

782 total citations
21 papers, 615 citations indexed

About

E. S. Henderson is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, E. S. Henderson has authored 21 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 10 papers in Genetics and 4 papers in Oncology. Recurrent topics in E. S. Henderson's work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). E. S. Henderson is often cited by papers focused on Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Chronic Myeloid Leukemia Treatments (5 papers). E. S. Henderson collaborates with scholars based in United States, United Kingdom and Canada. E. S. Henderson's co-authors include Tin Han, Lawrence J. Emrich, Howard Ozer, M L Bloom, Naoki Sadamori, GA Gomez, Anwarul Islam, Tor Knutsen, E. J. Freireich and A.A. Sandberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

E. S. Henderson

21 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. S. Henderson United States 13 316 283 191 170 142 21 615
Angeline Van Orshoven Belgium 15 291 0.9× 488 1.7× 163 0.9× 152 0.9× 111 0.8× 29 735
S Stass United States 10 247 0.8× 335 1.2× 172 0.9× 215 1.3× 160 1.1× 16 585
H. Löffler Germany 9 429 1.4× 478 1.7× 334 1.7× 125 0.7× 191 1.3× 28 818
SN Wolff United States 10 229 0.7× 421 1.5× 277 1.5× 145 0.9× 100 0.7× 13 822
G Dart Australia 9 118 0.4× 452 1.6× 117 0.6× 66 0.4× 102 0.7× 19 661
SN Rabinowe United States 10 333 1.1× 425 1.5× 348 1.8× 51 0.3× 256 1.8× 16 804
Bernadette Corront France 15 258 0.8× 464 1.6× 327 1.7× 155 0.9× 117 0.8× 28 797
Hagop M. Kantarjian United States 11 256 0.8× 437 1.5× 122 0.6× 318 1.9× 56 0.4× 17 650
TM Fliedner Germany 8 202 0.6× 549 1.9× 38 0.2× 88 0.5× 80 0.6× 13 648
RT Silver United States 9 281 0.9× 344 1.2× 141 0.7× 155 0.9× 101 0.7× 13 580

Countries citing papers authored by E. S. Henderson

Since Specialization
Citations

This map shows the geographic impact of E. S. Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. S. Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. S. Henderson more than expected).

Fields of papers citing papers by E. S. Henderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. S. Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. S. Henderson. The network helps show where E. S. Henderson may publish in the future.

Co-authorship network of co-authors of E. S. Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of E. S. Henderson. A scholar is included among the top collaborators of E. S. Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. S. Henderson. E. S. Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marković, Nataša, Olivera Marković, & E. S. Henderson. (2005). MarkPap test for cervical cancer screening. Journal of Clinical Oncology. 23(16_suppl). 1021–1021. 1 indexed citations
2.
Ellison, Rose Ruth, Rosemarie Mick, Janet Cuttner, et al.. (1991). The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B.. Journal of Clinical Oncology. 9(11). 2002–2015. 82 indexed citations
3.
Piedmonte, Marion, et al.. (1990). Splenectomy in advanced chronic lymphocytic leukemia.. PubMed. 4(11). 758–60. 11 indexed citations
4.
Islam, Anwarul, Bertha Frisch, & E. S. Henderson. (1989). Plastic embedded core biopsy: a complementary approach to bone marrow aspiration for diagnosing acute myeloid leukaemia.. Journal of Clinical Pathology. 42(3). 300–306. 6 indexed citations
5.
Islam, Anwarul & E. S. Henderson. (1988). Value of long‐core biopsy in the detection of discrete bone marrow lesions. Histopathology. 12(6). 641–648. 15 indexed citations
6.
Islam, Anwarul, E Archimbaud, E. S. Henderson, & Tao Han. (1988). Glycol methacrylate (GMA) embedding for light microscopy. II. Immunohistochemical analysis of semithin sections of undecalcified marrow cores.. Journal of Clinical Pathology. 41(8). 892–896. 12 indexed citations
7.
Islam, Anwarul & E. S. Henderson. (1987). Glycol methacrylate embedding for light microscopy. I. enzyme histochemistry on semithin sections of undecalcified marrow cores.. Journal of Clinical Pathology. 40(10). 1194–1200. 14 indexed citations
8.
Han, Tin, E. S. Henderson, Lawrence J. Emrich, & A. A. Sandberg. (1987). Prognostic significance of karyotypic abnormalities in B cell chronic lymphocytic leukemia: an update.. PubMed. 24(4). 257–63. 38 indexed citations
9.
Han, Tao, Lawrence J. Emrich, Howard Ozer, et al.. (1985). Clinical significance of serum lactate dehydrogenase in chronic lymphocytic leukemia.. PubMed. 85(12). 685–90. 3 indexed citations
10.
Han, Tin, Howard Ozer, Naoki Sadamori, et al.. (1984). Prognostic Importance of Cytogenetic Abnormalities in Patients with Chronic Lymphocytic Leukemia. New England Journal of Medicine. 310(5). 288–292. 141 indexed citations
11.
Han, Tao, Naoki Sadamori, Howard Ozer, et al.. (1984). Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data.. Journal of Clinical Oncology. 2(10). 1121–1132. 49 indexed citations
12.
Henderson, E. S.. (1983). Current Prospects for Clinical Care of Acute Leukemia. Hämatologie und Bluttransfusion. 28. 156–160. 1 indexed citations
13.
Henderson, E. S.. (1979). Progress in Acute Leukemia 1975–1978. Hämatologie und Bluttransfusion. 23. 163–168. 1 indexed citations
14.
Harguindey, Salvador, et al.. (1979). Hypercalcemia complicating childhood malignancies.A report of seven cases with some pathophysiological considerations. Cancer. 44(6). 2280–2290. 19 indexed citations
15.
Mutz, I, G. Bennett Humphrey, & E. S. Henderson. (1976). ?Chronic myelogenous? leukemia of juvenile type. European Journal of Pediatrics. 121(4). 227–236. 5 indexed citations
16.
Dindogru, Aydin, et al.. (1975). INDOMETHACIN IN HYPERCALCÆMIA. The Lancet. 306(7930). 365–365. 7 indexed citations
17.
Graw, R. G., Ronald A. Yankee, G. Nicholas Rogentine, et al.. (1972). BONE MARROW TRANSPLANTATION FROM HL-A-MATCHED DONORS TO PATIENTS WITH ACUTE LEUKEMIA TOXICITY AND ANTILEUKEMIC EFFECT. Transplantation. 14(1). 79–90. 25 indexed citations
18.
Gallelli, Joseph F., et al.. (1972). Hematuria and Crystalluria after High-Dose 6-Mercaptopurine Administration. New England Journal of Medicine. 287(6). 292–294. 12 indexed citations
19.
Whang‐Peng, Jacqueline, E. S. Henderson, Tor Knutsen, E. J. Freireich, & John J. Gart. (1970). Cytogenetic Studies in Acute Myelocytic Leukemia with Special Emphasis on the Occurrence of Ph1 Chromosome. Blood. 36(4). 448–457. 91 indexed citations
20.
Li, FrederickP., et al.. (1970). POSSIBLE INHERITED LEUKÆMOGENIC FACTORS IN FAMILIAL ACUTE MYELOGENOUS LEUKÆMIA. The Lancet. 295(7647). 586–589. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angeline Van Orshoven Breakdown of academic impact, for papers by S Stass Breakdown of academic impact, for papers by H. Löffler Breakdown of academic impact, for papers by SN Wolff Breakdown of academic impact, for papers by G Dart Breakdown of academic impact, for papers by SN Rabinowe Breakdown of academic impact, for papers by Bernadette Corront Breakdown of academic impact, for papers by Hagop M. Kantarjian Breakdown of academic impact, for papers by TM Fliedner Breakdown of academic impact, for papers by RT Silver
Rankless by CCL
2026